In the earlier post, the pre-grant objections to the Valganciclovir application of Roche were discussed (which had some really earthy and practical comments on interpretation of s.8 of the Patents Act, notably by Indian Patent Agent). According to news reports and updates by Lawyers Collective, the Supreme Court has ordered Roche not to pursue the patent infringement case against Cipla until such time the post-grant oppositions against the patent have been disposed off. The Court has asked the Controller to dispose the opposition proceedings within 12 weeks after which the remaining issues would be listed before the Court. Roche too, for its part has given an undertaking that it shall not seek an order restraining others from selling generic versions of the drug. The Court further said that the NGOs could intervene in the opposition proceedings and could raise all grounds to oppose the grant of the patent.